可解释机器学习用于生存分析
Sophie Hanna Langbein1,2, Mateusz Krzyziński3, Mikołaj Spytek3
1Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Biometrical journal. Biometrische Zeitschrift
|October 31, 2025
概括
可解释机器学习 (IML) 对于医疗保健中的透明生存分析至关重要. 本研究回顾了IML方法,并展示了它们用于理解模型预测和识别风险因素的应用.
科学领域:
- 机器学习 机器学习
- 人工智能的人工智能
- 生物统计学 生物统计学
背景情况:
- 复杂的生命的扩散.
- 黑盒子是一个黑盒子.
- 机器学习 (ML) 模型需要开发可解释的机器学习 (IML) 或可解释的人工智能 (XAI) 技术.
- IML对于医疗保健中的生存分析至关重要,确保临床决策,治疗开发和风险预测的透明度,问责制和公平性.
- 缺乏可访问的IML方法阻碍了ML用于时间到事件数据分析的采用.
研究的目的:
- 提供适用于生存分析的现有IML方法的全面审查.
- 调整和详细应用常见的IML技术 (ICE,PDP,ALE,特征重要性,弗里德曼的H相互作用) 对生存结果.
- 为研究人员在生存分析中使用IML提供实用指南.
主要方法:
- 在一般的IML分类学中对IML文献进行系统审查.
- 已建立的IML方法对生存数据的正式调整.
- 选择的IML方法对乳腺癌复发数据的实证应用 (GBSG2).
主要成果:
- 介绍了适用于生存分析的IML技术的结构化概述.
- 演示如何标准IML方法可以有效地修改为时间到事件预测.
- 从将IML应用于真实世界乳腺癌数据中获得的实用见解.
结论:
- 这项工作弥合了IML方法论与其在生存分析中的实际实施之间的差距.
- 适应的IML方法提高了对生存模型的理解,促进了偏差检测和特征影响识别.
- 该教程应用程序使研究人员能够利用IML在医疗环境中获得更可靠和可解释的生存预测.
更多相关视频
相关概念视频
Survival Tree
379
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
379
Introduction To Survival Analysis
735
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
735
Assumptions of Survival Analysis
388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
Comparing the Survival Analysis of Two or More Groups
548
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
548
Truncation in Survival Analysis
569
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
569
Cancer Survival Analysis
639
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
639


